Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Devine

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2020
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisMehdi Hamadani, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trialRichard T Maziarz, Timothy Devos, Carlos R Bachier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Leukemia & Lymphoma|February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experienceFiliz Yucebay, Christina Matthews, Marcin Puto, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2017
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin LymphomaJoseph J Maly, Beth A Christian, Xiaohua Zhu, et al.
Blood Advances|April 30, 2024
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastimHeather E Stefanski, Michelle Kuxhausen, Stephanie Bo-Subait, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303Carolyn A Keever-Taylor, Steven M Devine, Robert J Soiffer, et al.
Journal of Hematology & Oncology|June 14, 2017
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphomaNarendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2020
Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease ProphylaxisMehdi Hamadani, Mei-Jie Zhang, Xiao-Ying Tang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trialRichard T Maziarz, Timothy Devos, Carlos R Bachier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2011
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303Steven M Devine, Shelly Carter, Robert J Soiffer, et al.
Leukemia & Lymphoma|February 16, 2019
Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experienceFiliz Yucebay, Christina Matthews, Marcin Puto, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 10, 2015
Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphomaJonathon B Cohen, Amy S Ruppert, Nyla A Heerema, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2017
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin LymphomaJoseph J Maly, Beth A Christian, Xiaohua Zhu, et al.
Blood Advances|April 30, 2024
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastimHeather E Stefanski, Michelle Kuxhausen, Stephanie Bo-Subait, et al.
Blood|May 6, 2017
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host diseaseYi-Bin Chen, Miguel-Angel Perales, Shuli Li, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 31, 2011
Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303Carolyn A Keever-Taylor, Steven M Devine, Robert J Soiffer, et al.
Journal of Hematology & Oncology|June 14, 2017
Rituximab-containing reduced-intensity conditioning improves progression-free survival following allogeneic transplantation in B cell non-Hodgkin lymphomaNarendranath Epperla, Kwang Woo Ahn, Sairah Ahmed, et al.
Pageof 18